The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection
Open accessAbstract
Summary During mammalian pregnancy, the placenta acts as a barrier between the maternal and fetal compartments. The recently observed association between Zika virus (ZIKV) infection during human pregnancy and fetal microcephaly and other anomalies suggests that ZIKV may bypass the placenta to reach the fetus. This led us to investigate ZIKV infection of primary human trophoblasts (PHT), which are the barrier cells of the placenta. We discovered that PHT cells from full-term placentas are refractory to ZIKV infection. In addition, medium from uninfected PHT cells protects non-placental cells from ZIKV infection. PHT cells constitutively release the type III interferon (IFN) IFNλ1, which functions in both a paracrine and autocrine manner to protect trophoblast and non-trophoblast cells from ZIKV infection. Our data suggests that for ZIKV to access the fetal compartment, it must evade restriction by trophoblast-derived IFNλ1 and other trophoblast-specific antiviral factors and/or use alternative strategies to cross the placental barrier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
Zika Virus Associated with Microcephaly
Mlakar, J., Korva, M., Tul, N., Popović, M., Poljšak-Prijatelj, M., Mraz, J., Kolenc, M., Resman Rus, K., Vesnaver Vipotnik, T., Fabjan Vodušek, V., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600651 · Cited by 2,884 · cited 1×
“While direct evidence for a causal relationship between ZIKV infections and the development of abnormal pregnancy outcomes is still emerging, recent reports have directly identified the presence of viral RNA (vRNA) and infectious virus in the placentas, amniotic cavity, and brains of fetuses that had developed fetal a…”
BackgroundA diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Zika Virus Infection in Pregnant Women in Rio de Janeiro
Brasil, P., Pereira, J. P., Moreira, M. E., Ribeiro Nogueira, R. M., Damasceno, L., Wakimoto, M., Rabello, R. S., Valderramos, S. G., Halai, U.-A., Salles, T. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602412 · Cited by 2,196
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
KLIMAN, H. J., NESTLER, J. E., SERMASI, E., SANGER, J. M., & STRAUSS, J. F. (1986) · Endocrinology · doi:10.1210/endo-118-4-1567 · Cited by 1,574
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
Oliveira Melo, A. S., Malinger, G., Ximenes, R., Szejnfeld, P. O., Alves Sampaio, S., & Bispo de Filippis, A. M. (2016) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.15831 · Cited by 1,180
Calvet, G., Aguiar, R. S., Melo, A. S. O., Sampaio, S. A., de Filippis, I., Fabri, A., Araujo, E. S. M., de Sequeira, P. C., de Mendonça, M. C. L., de Oliveira, L., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00095-5 · Cited by 1,165
Cited by
Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure
Qian, X., Nguyen, H. N., Song, M. M., Hadiono, C., Ogden, S. C., Hammack, C., Yao, B., Hamersky, G. R., Jacob, F., Zhong, C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.032 · Cited by 2,127
“Two recent studies have shown few differences between properties of different ZIKV strains in different models (Bayer et al., 2016; Lazear et al., 2016).”
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
The continued threat of emerging flaviviruses
Pierson, T. C., & Diamond, M. S. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0714-0 · Cited by 1,098
Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise
Miner, J. J., Cao, B., Govero, J., Smith, A. M., Fernandez, E., Cabrera, O. H., Garber, C., Noll, M., Klein, R. S., Noguchi, K. K., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.008 · Cited by 812
Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling
Grant, A., Ponia, S. S., Tripathi, S., Balasubramaniam, V., Miorin, L., Sourisseau, M., Schwarz, M. C., Sánchez-Seco, M. P., Evans, M. J., Best, S. M., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.05.009 · Cited by 797
Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development
Yockey, L. J., & Iwasaki, A. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.017 · Cited by 559
Krauer, F., Riesen, M., Reveiz, L., Oladapo, O. T., Martínez-Vega, R., Porgo, T. V., Haefliger, A., Broutet, N. J., Low, N., & WHO Zika Causality Working Group (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002203 · Cited by 492
Tabata, T., Petitt, M., Puerta-Guardo, H., Michlmayr, D., Wang, C., Fang-Hoover, J., Harris, E., & Pereira, L. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.002 · Cited by 486
Zika Virus Infects Human Placental Macrophages
Quicke, K. M., Bowen, J. R., Johnson, E. L., McDonald, C. E., Ma, H., O’Neal, J. T., Rajakumar, A., Wrammert, J., Rimawi, B. H., Pulendran, B., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.05.015 · Cited by 475
Infections at the maternal–fetal interface: an overview of pathogenesis and defence
Megli, C. J., & Coyne, C. B. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00610-y · Cited by 442
Self-citationZika Virus Pathogenesis and Tissue Tropism
Miner, J. J., & Diamond, M. S. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.01.004 · Cited by 417
The emergence of Zika virus and its new clinical syndromes
Pierson, T. C., & Diamond, M. S. (2018) · Nature · doi:10.1038/s41586-018-0446-y · Cited by 391
Microbial Vertical Transmission during Human Pregnancy
Arora, N., Sadovsky, Y., Dermody, T. S., & Coyne, C. B. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.04.007 · Cited by 382
Self-citationVaginal Exposure to Zika Virus during Pregnancy Leads to Fetal Brain Infection
Yockey, L. J., Varela, L., Rakib, T., Khoury-Hanold, W., Fink, S. L., Stutz, B., Szigeti-Buck, K., Van den Pol, A., Lindenbach, B. D., Horvath, T. L., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.004 · Cited by 363
Zika virus — reigniting the TORCH
Coyne, C. B., & Lazear, H. M. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.125 · Cited by 355
Self-citationLi, C., Deng, Y.-Q., Wang, S., Ma, F., Aliyari, R., Huang, X.-Y., Zhang, N.-N., Watanabe, M., Dong, H.-L., Liu, P., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.012 · Cited by 344
Zika virus: History, epidemiology, transmission, and clinical presentation
Song, B.-H., Yun, S.-I., Woolley, M., & Lee, Y.-M. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.03.001 · Cited by 343
Biochemistry and Molecular Biology of Flaviviruses
Barrows, N. J., Campos, R. K., Liao, K.-C., Prasanth, K. R., Soto-Acosta, R., Yeh, S.-C., Schott-Lerner, G., Pompon, J., Sessions, O. M., Bradrick, S. S., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00719 · Cited by 341
Risks associated with viral infections during pregnancy
Racicot, K., & Mor, G. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87490 · Cited by 312
Zika virus inhibits type‐I interferon production and downstream signaling
Kumar, A., Hou, S., Airo, A. M., Limonta, D., Mancinelli, V., Branton, W., Power, C., & Hobman, T. C. (2016) · EMBO reports · doi:10.15252/embr.201642627 · Cited by 310
Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models
Delvecchio, R., Higa, L., Pezzuto, P., Valadão, A., Garcez, P., Monteiro, F., Loiola, E., Dias, A., Silva, F., Aliota, M., et al. (2016) · Viruses · doi:10.3390/v8120322 · Cited by 279
Immune Response to Dengue and Zika
Elong Ngono, A., & Shresta, S. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053142 · Cited by 268
Type I interferons instigate fetal demise after Zika virus infection
Yockey, L. J., Jurado, K. A., Arora, N., Millet, A., Rakib, T., Milano, K. M., Hastings, A. K., Fikrig, E., Kong, Y., Horvath, T. L., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aao1680 · Cited by 255
Self-citationEmerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes
Panchaud, A., Stojanov, M., Ammerdorffer, A., Vouga, M., & Baud, D. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00014-16 · Cited by 171
Contributions of maternal and fetal antiviral immunity in congenital disease
Yockey, L. J., Lucas, C., & Iwasaki, A. (2020) · Science · doi:10.1126/science.aaz1960 · Cited by 68
Metadata
- Authors
- Bayer, A., Lennemann, N. J., Ouyang, Y., Bramley, J. C., Morosky, S., Marques, E. T. D. A., Cherry, S., Sadovsky, Y., & Coyne, C. B.
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 19
- Issue
- 5
- Pages
- 705-712
- ISSN
- 1931-3128 (ISSN-L)
- OpenAlex
- W2326233293
- Cited by
- 546
- References
- 31
- FWCI
- 43.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.